^
    BIOMARKER:
    CDKN2A mutation
    i
    Other names: CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
    Entrez ID:
    1029
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    CDKN2A mutation
    Triple Negative Breast Cancer
    atezolizumab
    Sensitive
    :
    B
    CDKN2A mutation
    Breast Cancer
    ribociclib
    Resistant
    :
    B
    CDKN2A mutation
    Gallbladder Cancer
    palbociclib
    Resistant
    :
    C3
    CDKN2A mutation
    Clear Cell Renal Cell Carcinoma
    palbociclib
    Sensitive
    :
    C3
    CDKN2A mutation
    Pancreatic Cancer
    palbociclib
    Resistant
    :
    C3
    CDKN2A mutation
    Solid Tumor
    Immunotherapy
    Resistant
    :
    C3
    CDKN2A mutation
    Melanoma
    Immunotherapy
    Resistant
    :
    C3
    CDKN2A mutation
    Urothelial Cancer
    Immunotherapy
    Resistant
    :
    C3
    CDKN2A mutation
    SCCHN
    AZD1775 + VIC-1911
    Sensitive
    :
    D
    CDKN2A mutation
    NSCLC
    AZD1775 + VIC-1911
    Sensitive
    :
    D
    CDKN2A mutation
    Melanoma
    palbociclib
    Sensitive
    :
    D
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES